Data as of Oct 24
| -0.11 / -1.38%|
The 4 analysts offering 12-month price forecasts for MEI Pharma Inc have a median target of 15.50, with a high estimate of 22.00 and a low estimate of 14.00. The median estimate represents a +97.70% increase from the last price of 7.84.
The current consensus among 5 polled investment analysts is to Buy stock in MEI Pharma Inc. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.